# Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2

> **NCT00050726** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 620 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Interleukin-2

## Key facts

- **NCT ID:** NCT00050726
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-05
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 620 (—)
- **Last updated:** 2013-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00050726

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00050726, "Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00050726. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*